- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04139603
Effects of Two Different Kinesio Taping Applications on Pain and Functional Mobility in Pregnants With Lumbopelvic Pain
Gebeliğe Bağlı Lumbopelvik Ağrıda İki Farklı Kinezyo Bant Uygulamasının Ağrı ve Fonksiyonel Mobilite Üzerine Etkisi
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Literature studies on the effectiveness of kinesio taping (KT) in pregnancy related lumbopelvic pain (LPP) are limited in number and have methodological shortcomings such as lack of randomization, a control group or assessor and/or patient blindness. Although generally presenting a significant effectiveness of KT on intensity of pain and disability, these parameters are evaluated by subjective methods, and the findings do not rely on quantitative data, in general.
In addition, the intervention parameters used in these studies, such as the KT techniques used, amount of KT tension and duration of the intervention are different from each other, and there is lack of studies comparing the effectiveness of different KT techniques.
In this study, effectiveness of two different KT applications will be compared with placebo KT:
- Lumbopelvic KT (LPKT): Two I-shaped kinesio tapes in 40 cm length will be applied bilaterally, beginning from 5 cm below the spina iliaca posterior superiors (SIPSs) to the level of the 12th costae, in maximum trunk flexion position, on the paravertebral muscles, by inhibition technique of muscle correction techniques. The tapes will be placed with no tension at 5 cm of both ends, and with 15-25% tension in between. In addition, an extra I-shaped tape will be placed perpendicullar to these tapes with the ligament correction technique, while the pregnant women are in the vertical upright position, at the level of the sacroiliac joints, starting with a tensile strength of 75-100% from the middle, and then with no tension at two ends.
- Abdominal supported LPKT (ALPKT): An abdominal support tape will be added to the LPKT. In order to reduce the tension of the uterus ligaments, and to help perception of the normal elasticity of the target tissues, ligament technique will be used. The middle part of an I-shaped tape will be placed to the midpoint of the lower abdomen, and then will be progressed laterally and above with 50% tension.
For placebo application, a Micropore™ surgical plaster of the same color with KT will be applied with no tension, as described in the LPKT technique.
All participants will undergo a 45-60 minutes of standard ergonomic education after initial assessments and following the first taping applications, They will be observed in regard to their behaviours during different activities such as standing, sitting, walking, turning in bed and standing from the bed. Necessary warnings will be given about correcting their posture and behaviors in terms of ergonomic principles.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Zeynep Kamil Women's and Children's Disease Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- being able to read and write in Turkish,
- being in 2nd or 3rd trimester of pregnancy,
- having lumbar or pelvic girdle pain for at least one week
- signing the informed consent form for the study
Exclusion Criteria:
- visual, auditory or cognitive problems which may prevent participation to the study
- health problems other than pregnancy related lumbopelvic pain (orthopedic, neurologic, cardiorespiratory, etc.) or trauma history, which may affect standing from sitting, walking or stair climbing activities
- Any gynecological or urological problems which may mimic pregnancy related lumbopelvic pain
- Any ddiagnosed pregnancy complications (preeclampsy, pregnancy related hypertension, diabetes, fetal anomaly, etc.)
- Multiple gestation
- History of spinal injury, ankylosing spondilitis, rheumatoid arthritis, intervertebral disc pathology
- Positive straight leg raising test result or peripheral sensory or motor impairments which may indicate lumbar interbertebral disc pathology
- History of prepregnancy low back pain
- Using any analgesic or myorelaxant medication
- Contraindications to KT (impaired skin integrity or lesion in the lumbopelvic and abdominal regions, history of allergic reaction, etc.)
- previous KT experience
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Lumbopelvic kinesio taping (LPKT)
Two I-shaped kinesio tapes in 40 cm length will be applied bilaterally, beginning from 5 cm below the spina iliaca posterior superiors (SIPSs) to the level of the 12th costae, in maximum trunk flexion position, on the paravertebral muscles, by inhibition technique of muscle correction techniques.
The tapes will be placed with no tension at 5 cm of both ends, and with 15-25% tension in between.
In addition, an extra I-shaped tape will be placed perpendicullar to these tapes with the ligament correction technique, while the pregnant women are in the vertical upright position, at the level of the sacroiliac joints, starting with a tensile strength of 75-100% from the middle, and then with no tension at two ends.
|
Kinesio tapes applied to the lumbopelvic region will stay 3 days. They will be removed from the site, and the skin will be checked and cleaned, and then reapplied for the next 3 days. An ergonomic education program will be given after the baseline measurements, and will last for 45-60 minutes. A brochure including ergonomic principles with images will also be provided.
Other Names:
|
|
Experimental: Abdominal supported lumbopelvic kinesio taping (ALPKT)
An abdominal support tape will be added to the LPKT.
In order to reduce the tension of the uterus ligaments, and to help perception of the normal elasticity of the target tissues, ligament technique will be used.
The middle part of an I-shaped tape will be placed to the midpoint of the lower abdomen, and then will be progressed laterally and above with 50% tension.
|
Kinesio tapes applied to the lumbopelvic region and abdominal area will stay 3 days. They will be removed from the sites, and the skin will be checked and cleaned, and then reapplied for the next 3 days. An ergonomic education program will be given after the baseline measurements, and will last for 45-60 minutes. A brochure including ergonomic principles with images will also be provided.
Other Names:
|
|
Placebo Comparator: Placebo taping
A Micropore™ surgical plaster of the same color with KT will be applied with no tension, as described in the LPKT technique.
|
Placebo tapes (just like Kinesio tapes) applied to the lumbopelvic region without any tension will stay 3 days. They will be removed from the site, and the skin will be checked and cleaned, and then reapplied for the next 3 days. An ergonomic education program will be given after the baseline measurements, and will last for 45-60 minutes. A brochure including ergonomic principles with images will also be provided.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in pain intensity during resting
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
0 (no pain)-10 cm (unbearable pain) visual analogue scale will be used.
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
|
Change in pain intensity during timed up and go (TUG) test
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
0 (no pain)-10 cm (unbearable pain) visual analogue scales will be used.
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
|
Change in pain intensity during five times sit to stand test
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
0 (no pain)-10 cm (unbearable pain) visual analogue scales will be used.
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
|
Change in pain intensity during stair climbing test
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
0 (no pain)-10 cm (unbearable pain) visual analogue scales will be used.
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
|
Change in time of completing timed up and go test (seconds)
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
All participants will perform the test from a chair (height: 46 cm) with back-support.
They will be asked to stand up, walk three meters, turn around, walk back to the chair, and sit down as fast as they can.
Time to complete the test will be recorded (sec).
Lower times indicate better functional mobility level for walking.
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
|
Change in time of completing five times sit to stand test (seconds)
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
The participants will sit on a straight back chair (43 cm height) with arms folded across their chest.
They will be instructed to stand up and sit down as quickly as possible 5 times, keeping their arms folded across their chest.
Time for completing the test will be recorded (sec).
Lower times indicate better functional mobility level for sit to stand activity.
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
|
Change in time of completing stair climbing test (seconds)
Time Frame: baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
The participants will be asked to ascend and descend 10 stairs.
Time of completing the test will be recorded in seconds.
Lower times indicate better functional mobility level in stair activities
|
baseline, approximately one-hour after the first taping, three days after the first taping, and one week after the first taping
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in activity limitation
Time Frame: baseline, three days after the first taping, and one week after the first taping
|
Turkish version of Pelvic Girdle Questionnaire will be used.
Total score of the questionnaire varies between 0 and 75, and higher scores indicate higher activity limitation.
|
baseline, three days after the first taping, and one week after the first taping
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Reyhan AC, Dereli EE, Colak TK. Low back pain during pregnancy and Kinesio tape application. J Back Musculoskelet Rehabil. 2017;30(3):609-613. doi: 10.3233/BMR-160584.
- Kalinowski P, Krawulska A. Kinesio Taping vs. Placebo in Reducing Pregnancy-Related Low Back Pain: A Cross-Over Study. Med Sci Monit. 2017 Dec 26;23:6114-6120. doi: 10.12659/msm.904766.
- Kuciel N, Sutkowska E, Cienska A, Markowska D, Wrzosek Z. Impact of Kinesio Taping application on pregnant women suffering from pregnancy-related pelvic girdle pain - preliminary study. Ginekol Pol. 2017;88(11):620-625. doi: 10.5603/GP.a2017.0111.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 47921137-050.01.04-E.109998
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.